Lucy Scientific Discovery Inc. (LSDI)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	64.23M
Revenue (ttm)	n/a
Net Income (ttm)	-5.94M
Shares Out	16.06M
EPS (ttm)	-0.37
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About LSDI

Lucy Scientific Discovery is an early-stage psychotropics contract manufacturing company focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. In August 2021, Health Canada’s Office of Controlled Substances granted us a Controlled Drugs and Substances Dealer’s Licence. The Dealer’s Licence authorizes us to develop and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in contr...

• Industry: Health Care
• Sector: Pharmaceuticals
• Founded: 2017
• Country: Canada
• Stock Exchange: NASDAQ
• Ticker Symbol: LSDI